Natera
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
CEOStephen Leonard Chapman
CEOStephen Leonard Chapman
Employees4,434
Employees4,434
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded2003
Founded2003
Employees4,434
Employees4,434
NTRA Key Statistics
Market cap24.08B
Market cap24.08B
Price-Earnings ratio-92.05
Price-Earnings ratio-92.05
Dividend yield—
Dividend yield—
Average volume934.65K
Average volume934.65K
High today$177.49
High today$177.49
Low today$173.77
Low today$173.77
Open price$175.16
Open price$175.16
Volume608.85K
Volume608.85K
52 Week high$183.00
52 Week high$183.00
52 Week low$117.27
52 Week low$117.27
NTRA News
Simply Wall St 3d
How a Legal Settlement and New Rival Test Could Influence Natera’s Competitive StrategyIn the past week, Natera reached an $8.25 million settlement in a legal case and faced heightened competition after Exact Sciences launched a new multi-cancer e...
Analyst ratings
96%
of 23 ratingsBuy
95.7%
Hold
0%
Sell
4.3%
People also own
Based on the portfolios of people who own NTRA. This list is generated using Robinhood data, and it’s not a recommendation.